New Developments in Topical Acne Therapy
Autor: | Lara Drake, Sophia Reyes-Hadsall, John S. Barbieri, Arash Mostaghimi |
---|---|
Rok vydání: | 2022 |
Předmět: | |
Zdroj: | American Journal of Clinical Dermatology. 23:125-136 |
ISSN: | 1179-1888 1175-0561 |
DOI: | 10.1007/s40257-021-00666-9 |
Popis: | Acne vulgaris is a common chronic inflammatory disease with a multifactorial pathogenesis. Although myriad acne treatments are available, current options may not be sufficient because of a lack of efficacy, limited tolerability, or burden of cost to patients. In this review, we highlight recently approved topical acne treatments, as well as those currently in clinical trials. Novel formulations of tretinoin, tazarotene, and minocycline provide modifications of and improvements to existing products. Trifarotene, a novel fourth-generation retinoid, has demonstrated improved tolerability compared with existing topical retinoids. Clascoterone is a novel first-in-class antiandrogen that topically addresses the hormonal etiology of acne. The late-phase clinical trials pipeline consists of agents with bactericidal and anti-sebum mechanisms. Although it is evident that acne treatments continue to evolve, it is important to recognize the need for further comparative studies among new and existing agents to define optimal treatment algorithms that address not only safety and efficacy but also cost-effective care. |
Databáze: | OpenAIRE |
Externí odkaz: |